The World Health Organization said on April 5 it will supply thousands of doses of life-saving antiretroviral drugs to Ukraine to cover the needs of HIV patients in the country for the next 12 months.
Merck on Oct. 25 revealed positive results from two Phase III trials on a potential treatment for adults with HIV-1 infection and are virologically suppressed on different antiretroviral regimens (ART).
Gilead Sciences filed a lawsuit against the United States government alleging the U.S. Centers for Disease Control and Prevention (CDC) violated a contract that governed an HIV research collaboration between the company and government agency.
India’s ability to produce affordable generic drugs has led to the country’s reputation of being the “pharmacy of the world,” according to Dr. Reddy’s Vice President Radha Iyer.
The return on R&D investment for leading biopharmaceutical manufacturers fell to a nine-year low while the U.S. FDA approved a record-breaking amount of novel medicines during 2018.
Merck & Co. announced that the U.S. Food and Drug Administration accepted for review supplemental New Drug Applications (sNDAs) for Pifeltro and Delstrigo.